In addition, osteocalcin exerts protective effects on energy metabolism; thus, the obesity-related high FT3 may promote the secretion of osteocalcin to compensate for glucose and lipid metabolism. Here, BGLAP is linked to obesity due to melanocortin 4 receptor deficiency.